Biowatch

A Third Arm for Therapists: The Surgeon Bringing ‘Self-Driving’ Tech to Physical Rehab

A Third Arm for Therapists: The Surgeon Bringing ‘Self-Driving’ Tech to Physical Rehab

Artificial intelligence may be able to detect a patient’s disease, but it cannot move stiff arms and legs for them.
Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars

Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars

Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and oncology therapies.
Hanmi Pharmaceutical’s Paltan Smart Plant Cuts Drug Stockouts 57% Following Reorganization

Hanmi Pharmaceutical’s Paltan Smart Plant Cuts Drug Stockouts 57% Following Reorganization

Stockout cases have dropped sharply at Hanmi Pharmaceutical’s primary manufacturing base for synthetic drugs.
Roen Surgical’s Kidney Stone Robot Zamenix Secures US FDA Clearance

Roen Surgical’s Kidney Stone Robot Zamenix Secures US FDA Clearance

Zamenix, a kidney stone surgery robot developed by medical robotics company Roen Surgical, has received Class II...
Courier-Delivered ‘Baekok Shots’ Were Actually Intended for Neurological Disorders

Courier-Delivered ‘Baekok Shots’ Were Actually Intended for Neurological Disorders

Some consumers have been purchasing prescription-only injectable drugs online without a doctor’s oversight.
Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Major institutional asset managers are steadily increasing their equity stakes in South Korean pharmaceutical and...
550 Days in Limbo: Groups Demand 100-Day Fast-Track Insurance Coverage for Breakthrough PAH Drug Winrevair

550 Days in Limbo: Groups Demand 100-Day Fast-Track Insurance Coverage for Breakthrough PAH Drug Winrevair

With national health insurance coverage for the new pulmonary arterial hypertension treatment Winrevair (active...
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's...
[Reporter’s Notebook] Hanmi Group’s Internal Feuds Keep Invoking the ‘Lim Sung-ki Spirit.’ It Must Apply to Everyone

[Reporter’s Notebook] Hanmi Group’s Internal Feuds Keep Invoking the ‘Lim Sung-ki Spirit.’ It Must Apply to Everyone

Whenever a control dispute or internal conflict erupts at Hanmi Group, one phrase reliably resurfaces: the “Lim Sung-ki...
GC Biopharma Develops Advanced Platform to Track mRNA Vaccine Degradation

GC Biopharma Develops Advanced Platform to Track mRNA Vaccine Degradation

GC Biopharma has developed a technology platform capable of precisely analyzing how mRNA vaccines degrade when exposed...